Search Results - "Kosicka, K"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis by Kosicka, K, Cymerys, M, Majchrzak-Celińska, A, Chuchracki, M, Główka, F K

    Published in Journal of human hypertension (01-08-2013)
    “…11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyzes the inactivation of cortisol (F) to cortisone (E) in aldosterone target tissues, thereby protects…”
    Get full text
    Journal Article
  2. 2

    11[beta]-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis by Kosicka, K, Cymerys, M, Majchrzak-celinska, A, Chuchracki, M, Glówka, F K

    Published in Journal of human hypertension (01-08-2013)
    “…11[beta]-Hydroxysteroid dehydrogenase type 2 (11[beta]-HSD2) catalyzes the inactivation of cortisol (F) to cortisone (E) in aldosterone target tissues, thereby…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Bupivacaine administered intrathecally versus rectally in the management of intractable rectal cancer pain in palliative care by Zaporowska-Stachowiak, Iwona, Kowalski, Grzegorz, Luczak, Jacek, Kosicka, Katarzyna, Kotlinska-Lemieszek, Aleksandra, Sopata, Maciej, Główka, Franciszek

    Published in OncoTargets and therapy (01-01-2014)
    “…Unacceptable adverse effects, contraindications to and/or ineffectiveness of World Health Organization step III "pain ladder" drugs causes needless suffering…”
    Get full text
    Journal Article
  5. 5

    Lumbar paravertebral blockade as intractable pain management method in palliative care by Zaporowska-Stachowiak, Iwona, Kotlinska-Lemieszek, Aleksandra, Kowalski, Grzegorz, Kosicka, Katarzyna, Hoffmann, Karolina, Główka, Franciszek, Luczak, Jacek

    Published in OncoTargets and therapy (01-01-2013)
    “…Optimal symptoms control in advanced cancer disease, with refractory to conventional pain treatment, needs an interventional procedure. This paper presents…”
    Get full text
    Journal Article
  6. 6

    SUPPLEMENTS, ISOTONIC DRINKS, AND ENERGY DRINKS AS POTENTIAL SOURCES OF DIETARY EXPOSURE TO FLUORINE COMPOUNDS IN ATHLETES by Murawska, K, Kowaleczko, M, Kosicka, KE, Bazaczek, A, Rybicka, M, Chlubek, D

    Published in Fluoride (01-09-2012)
    “…Supplements and isotonic drinks are major components of the diet of athletes, whereas energy drinks are commonly used by nearly the entire population. The use…”
    Get full text
    Journal Article